Projects funded by the NCN
The role of 5-hydroxymethyluracil in chronic lymphocytic leukemia development
2020/39/O/NZ5/00852
Keywords:
5-hydroxymethyluracil SMUG1 chronic lymphocytic leukemia epigenetics
Descriptors:
- NZ5_1: Etiology of human diseases
- NZ5_3: Pathogenesis of human diseases
- NZ2_2: Genomics, transcriptomics, epigenomics
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny
woj.
Principal investigator (from the host institution):
dr hab. Daniel Stefan Gackowski
Number of co-investigators in the project: 2
Call: PRELUDIUM BIS 2 - announced on 2020-09-15
Amount awarded: 541 680 PLN
Project start date (Y-m-d): 2021-10-01
Project end date (Y-m-d): 2025-09-30
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Articles in post-conference publications (1)
- Levels of 5-hydroxymethyluracil in the DNA of Monoclonal B Lymphoma patients blood cellsAuthors:Bagińska, P., Starczak, M., Skalska-Bugała, A., Wasilów, A., Mijewski, P., Leśniewski, F., Wołowiec, A., Gackowska, L., Gawroński, M., Guz, J., Szpila, A., Zarakowska, E., Siomek-Górecka, A., Różalski, R., Gackowski, D., & Oliński, R.Conference:1st Epigenetics Society International Meeting "Epigenetics of Disease and Development (rok: 2023, tom: Epigenetics of Disease and Development, strony: 148-150), Wydawca: FrontiersData:konferencja 12-14 Oct 2023Status:PublishedDOI:10.3389/978-2-8325-1235-7 - link to the publication